Emerging clinical applications of selected biomarkers in melanoma

Michael T Tetzlaff1 Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Carlos A Torres-Cabala1 Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Penvadee Pattanaprichakul1 Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;3 Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Ronald P Rapini2 Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Victor G Prieto1 Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Jonathan L Curry1 Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2 Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Emerging clinical applications of selected biomarkers in melanoma

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Emerging clinical applications of selected biomarkers in melanoma

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date